Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Open in API
Filings indexed 1,418 across all filing types
Latest filing 2020-08-18 Regulatory Filings
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
National Comprehensive Cancer Network(R) Adds Monjuvi(R) (tafasitamab-cxix) to its Clinical Practice Guidelines in Oncology for B-cell Lymphomas
Regulatory Filings Classification · 1% confidence The document is a press release dated August 18, 2020, announcing that the drug Monjuvi (tafasitamab-cxix) has been added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for B-cell Lymphomas. This announcement details clinical and regulatory milestones (FDA approval, NCCN guideline inclusion) related to a pharmaceutical product. It is not a full Annual Report (10-K), an Interim Report (IR), a formal Audit Report (AR), or a transcript (CT). It is a specific announcement regarding a product's status and market acceptance, which falls under general corporate news or regulatory updates. Since it is a specific announcement about a drug's inclusion in clinical guidelines, it is best classified as a general Regulatory Filing (RNS) or potentially an Earnings Release (ER) if it were tied to quarterly results, but here it is a standalone news item about clinical/regulatory progress. Given the options, RNS serves as the best general category for specific, non-financial, non-management-change regulatory/clinical news that doesn't fit other specific codes like DIV or CAP. It is not a Report Publication Announcement (RPA) because it is the news itself, not an announcement *about* attaching a report.
2020-08-18 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under German Securities Trading Act (WpHG) regulations. It details changes in the percentage of voting rights held by BlackRock, Inc. in MorphoSys AG, crossing specific thresholds (4.59% direct voting rights). This content directly corresponds to notifications required when major shareholders change their stake, which aligns perfectly with the definition of 'Major Shareholding Notification'. The code for this is MRQ.
2020-08-18 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' concerning BlackRock, Inc.'s voting rights in MorphoSys AG, detailing the acquisition/disposal of shares and instruments, and crossing a threshold on August 10, 2020. This content directly corresponds to the definition of a notification regarding changes in significant share ownership levels, which aligns with the 'Major Shareholding Notification' category (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the core content is the change in holding percentage, making MRQ more specific than DVA (Declaration of Voting Results) or RNS (General Regulatory Filing).
2020-08-17 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under Section 1. It details changes in voting rights percentages (e.g., from 4.85% to 4.76%) held by BlackRock, Inc. in MorphoSys AG, referencing specific German securities law articles (WpHG). This content directly corresponds to the definition of a Major Shareholding Notification, which is classified as 'MRQ' in the provided schema.
2020-08-13 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under German Securities Trading Act (WpHG) regulations. It details changes in voting rights percentages (e.g., 4.85% new total) held by a major shareholder (BlackRock, Inc.). This content directly corresponds to the definition of a notification regarding changes in significant share ownership levels, which aligns best with the 'Major Shareholding Notification' category (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the core content is the change in holding percentage, not the results of a vote (DVA).
2020-08-12 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' regarding BlackRock, Inc. crossing or reaching a threshold of voting rights on 04 Aug 2020, detailing the percentage changes. This content directly corresponds to regulatory filings concerning changes in significant share ownership. Among the provided definitions, 'Major Shareholding Notification' (Code: MRQ) is the most appropriate fit for reporting changes in significant share ownership levels crossing thresholds, as opposed to general regulatory filings (RNS) or director dealings (DIRS).
2020-08-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.